首页> 外文OA文献 >Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library
【2h】

Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library

机译:使用选自噬菌体展示的Fab文库的Fab片段分析尿激酶原和尿激酶纤溶酶原激活物抑制剂-1复合物与低密度脂蛋白受体相关蛋白的结合

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP) mediates endocytosis of a number of structurally unrelated ligands, including complexes of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) or urokinase plasminogen activator (u-PA), free t-PA, single-chain urokinase (pro-u-PA), alpha 2-macroglobulin-protease complexes, and lipoprotein lipase. So far, all ligands have in common the fact that they bind to the receptor in a Ca(2+)-dependent way and the fact that binding to the receptor can be inhibited by a 39-40-kDa protein, termed the receptor-associated protein. To obtain inhibitory antibodies for the analysis of the structure and function of the receptor we applied the combinatorial immunoglobulin repertoire cloning technique in order to specifically select monoclonal Fab fragments directed against Ca(2+)-dependent epitopes. In this report we describe the isolation of a Fab fragment (Fab A8) showing a high relative affinity for the receptor (0.5 nM). The binding of this Fab fragment to purified LRP is inhibited in the presence of 5 mM EDTA, receptor-associated protein, and lipoprotein lipase (IC50 values of 1.4 and 31 nM, respectively). By immunoblotting of CNBr-digested LRP it is shown that Fab A8 binds to a fragment that harbors the second cluster of cysteine-rich complement-type repeats flanked by epidermal growth factor repeats. Binding studies using 125I-labeled ligands and immobilized receptor show that Fab A8 partially inhibits the binding of [125I]u-PA.PAI-1 complexes (IC50 = 1.1 nM) and completely inhibits the binding of [125I]pro-u-PA to the receptor (IC50 = 2.2 nM). No inhibition was observed for the binding of 125I-labeled methylamine-activated alpha 2-macroglobulin or [125I]t-PA.PAI-1 to LRP. Degradation of [125I]u-PA.PAI-1 complexes by COS-1 cells was also partially (43%) inhibited by Fab A8. Our results provide evidence for the presence of an interaction site for pro-u-PA localized in the second cluster of cysteine-rich repeats that is unrelated to the t-PA.PAI-1 or methylamine-activated alpha 2-macroglobulin interaction sites
机译:低密度脂蛋白受体相关蛋白/α2-巨球蛋白受体(LRP)介导许多结构无关的配体的内吞作用,包括纤溶酶原激活物抑制剂1型(PAI-1)和组织型纤溶酶原激活物(t-PA)的复合物)或尿激酶纤溶酶原激活剂(u-PA),游离t-PA,单链尿激酶(pro-u-PA),α2-巨球蛋白-蛋白酶复合物和脂蛋白脂肪酶。到目前为止,所有配体都有一个共同的事实,即它们以Ca(2+)依赖的方式与受体结合,并且与受体的结合可以被称为受体-39的39-40 kDa蛋白抑制。相关蛋白。为了获得抑制性抗体来分析受体的结构和功能,我们应用了组合免疫球蛋白库全克隆技术,以便特异性地选择针对Ca(2+)依赖表位的单克隆Fab片段。在此报告中,我们描述了对片段具有高相对亲和力(0.5 nM)的Fab片段(Fab A8)的分离。在5 mM EDTA,受体相关蛋白和脂蛋白脂肪酶(IC50分别为1.4和31 nM)的存在下,该Fab片段与纯化LRP的结合受到抑制。通过CNBr消化的LRP的免疫印迹显示,Fab A8结合了一个片段,该片段带有表皮生长因子重复序列两侧的富含半胱氨酸的补体型重复序列的第二簇。使用125I标记的配体和固定受体的结合研究表明,Fab A8部分抑制[125I] u-PA.PAI-1复合物的结合(IC50 = 1.1 nM),并完全抑制[125I] u-PA.PAI-1的结合受体(IC50 = 2.2 nM)。没有观察到125I标记的甲胺活化的α2-巨球蛋白或[125I] t-PA.PAI-1与LRP结合的抑制作用。 Fab A8还抑制了COS-1细胞对[125I] u-PA.PAI-1复合物的降解(43%)。我们的结果提供了证据,表明存在一个与u-PA相互作用的位点,该位点位于与t-PA.PAI-1或甲胺活化的α2-巨球蛋白相互作用位点无关的富含半胱氨酸重复序列的第二个簇中

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号